| Product Code: ETC10081572 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Industry Life Cycle |
3.4 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Porter's Five Forces |
3.5 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine in Vietnam |
4.2.2 Growing awareness and adoption of pharmacogenomics technology |
4.2.3 Government initiatives to promote precision medicine and healthcare innovation |
4.3 Market Restraints |
4.3.1 Limited infrastructure and expertise in pharmacogenomics technology |
4.3.2 High cost associated with implementing theranostics and companion diagnostics |
4.3.3 Regulatory hurdles and lack of clear guidelines for personalized medicine in Vietnam |
5 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Trends |
6 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Types |
6.1 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.4 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By In-situ Hybridization, 2021- 2031F |
6.1.5 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.1.7 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.4 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.5 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.2.6 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Export to Major Countries |
7.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Imports from Major Countries |
8 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Key Performance Indicators |
8.1 Number of healthcare providers offering pharmacogenomics testing services |
8.2 Adoption rate of theranostics and companion diagnostics in clinical practice |
8.3 Research and development investment in precision medicine technologies |
8.4 Number of partnerships and collaborations in the pharmacogenomics sector |
8.5 Patient outcomes and healthcare cost savings attributed to personalized medicine initiatives |
9 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Opportunity Assessment |
9.1 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Competitive Landscape |
10.1 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Pharmacogenomics Technology Theranostics Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here